Systimmune

Develops bispecific antibodies and ADCs

Director Protein Engineering

Translational Research & Bench BiologyConfirmed live in the last 24 hours

Full-timeBothell, WA, USA$180k - $240k /yrIn-person

About the Job

Requirements

A PhD in protein engineering, biochemistry, structural biology, molecular biology, bioengineering, or a related field is required.
At least 10 years of industry experience in biologics drug discovery and development is required.
At least 8 years of hands-on yeast display experience, including library design and construction, fluorescence-activated cell sorting (FACS)-based selection and sorting, deep sequencing analysis, and downstream characterization of selected binders is required.
Experience building or substantially advancing a yeast display platform, including integration with laboratory automation such as liquid handlers, automated cell sorters, and LIMS or equivalent, is required.
A track record leading and developing scientists and research associates, including hiring, mentoring, performance management, and career progression, is required.
Demonstrated delivery of engineered binders or therapeutic leads into a biologics pipeline, ideally including bi-specific or multi-specific formats, is required.
Strong working knowledge of antibody and binder formats, including IgG, Fab, scFv, and VHH, and engineering strategies such as affinity maturation, stability and developability optimization, and conditional activation, is required.
Excellent scientific judgment and the ability to make timely, decisive calls on campaign strategy, hit triage, and resource allocation are required.
Strong written and verbal communication skills, including the ability to represent the function to senior leadership and external partners, are required.

Responsibilities

Lead, mentor, and develop a team of scientists and research associates by setting technical direction, performance expectations, and career development paths.
Build team structure, hiring plans, and resource allocation to match pipeline demand; partner with HR on recruiting, onboarding, and retention.
Establish team operating rhythms, including project reviews, technical reviews, and platform roadmap planning.
Own and advance the next-generation yeast display platform, including library design, surface display formats, selection workflows, and downstream characterization.
Integrate the yeast display platform with the FUSE automation wet lab, including liquid handling, automated sorting workflows, cell-free expression, and LIMS and data infrastructure.
Define platform performance metrics for throughput, diversity, hit rate, and developability, and lead continuous improvement against them.
Evaluate and onboard new technologies, instrumentation, and methodologies; build the case and budget for capital investments when warranted.
Direct display-based discovery and engineering campaigns for bi-specific and multi-specific antibodies, ADC binder components, and effector molecules across oncology programs.
Lead engineering strategy for affinity modulation, stability and developability optimization, epitope masking, conditional activation (pH, protease, etc.), and other novel binder properties.
Represent FUSE on project teams and at portfolio reviews; translate program needs into platform deliverables and timelines.
Ensure data quality, reproducibility, and integrity across the team; oversee SOPs, LIMS usage, and documentation standards.
Use NGS, flow cytometry, and computational tools to inform iterative protein design and lead selection.
Stay current on protein engineering, display technology, and lab automation; bring relevant advances into the platform.

Desired Qualifications

Experience leading display campaigns alongside complementary discovery modalities, including phage display, immunization-derived repertoires, or in silico/AI-based design.
Experience in oncology biologics, ADCs, or T cell engagers.
Familiarity with computational and machine learning approaches to library design and binder optimization.
Experience presenting at scientific conferences, contributing to patents, and publishing in peer-reviewed journals.

SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Bothell, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success.

SystImmune is seeking a Director of Protein Engineering to lead the FUSE team. This is a hands-on scientific leadership role that combines team management, platform ownership, and program-level decision making across the company’s bi-specific, multi-specific antibody, and ADC pipeline. The Director will own and continue evolving the next-generation yeast display platform built to integrate directly with the FUSE automation wet lab, lead a team of scientists and research associates executing display-based discovery and engineering campaigns, and partner closely with discovery biology, antibody discovery, CMC, and computational teams to deliver optimized lead molecules into the pipeline.

This is a full-time onsite position in Bothell, WA.

Key Responsibilities
Leadership and team management
Lead, mentor, and develop a team of scientists and research associates, setting clear technical direction, performance expectations, and career development paths. Build team structure, hiring plans, and resource allocation to match pipeline demand; partner with HR on recruiting, onboarding, and retention. Establish team operating rhythms, including project reviews, technical reviews, and platform roadmap planning.

Platform ownership: next-generation yeast display
Own and advance the next-generation yeast display platform, including library design, surface display formats, selection workflows, and downstream characterization. Drive integration of the yeast display platform with the FUSE automation wet lab, including liquid handling, automated sorting workflows, cell-free expression, and LIMS/data infrastructure. Define platform performance metrics (throughput, diversity, hit rate, developability) and lead continuous improvement against those metrics. Evaluate and onboard new technologies, instrumentation, and methodologies; build the case and budget for capital investments where warranted.

Program and pipeline impact
Direct display-based discovery and engineering campaigns for bi-specific and multi-specific antibodies, ADC binder components, and effector molecules across oncology programs. Lead engineering strategy for affinity modulation, stability and developability optimization, epitope masking, conditional activation (pH, protease, etc.), and other novel binder properties. Represent FUSE on project teams and at portfolio reviews; translate program needs into platform deliverables and timelines.

Scientific rigor and operations
Ensure data quality, reproducibility, and integrity across the team; oversee SOPs, LIMS usage, and documentation standards. Use NGS, flow cytometry, and computational tools to inform iterative protein design and lead selection. Stay current on the protein engineering, display technology, and lab automation landscape; bring relevant advances into the platform.

Qualifications

PhD in protein engineering, biochemistry, structural biology, molecular biology, bioengineering, or a related field.
Minimum 10 years of industry experience in biologics drug discovery and development.
Minimum 8 years of hands-on experience with yeast display, including library design and construction, FACS-based selection and sorting, deep sequencing analysis, and downstream characterization of selected binders.
Demonstrated experience building or substantially advancing a yeast display platform, including integration with laboratory automation (liquid handlers, automated cell sorters, LIMS, or equivalent).
Track record leading and developing a team of scientists and research associates, with clear examples of hiring, mentoring, performance management, and career progression.
Demonstrated delivery of engineered binders or therapeutic leads into a biologics pipeline, ideally including bi-specific or multi-specific formats.
Strong working knowledge of antibody and binder formats (IgG, Fab, scFv, VHH) and engineering strategies including affinity maturation, stability and developability optimization, and conditional activation.
Experience leading display campaigns alongside complementary discovery modalities (phage display, immunization-derived repertoires, in silico/AI-based design) is strongly preferred.
Excellent scientific judgment and the ability to make timely, decisive calls on campaign strategy, hit triage, and resource allocation.
Strong written and verbal communication skills, with the ability to represent the function to senior leadership and external partners.

Preferred Qualifications

Experience in oncology biologics, ADCs, or T cell engagers.
Familiarity with computational and machine learning approaches to library design and binder optimization.
Experience presenting at scientific conferences, contributing to patents, and publishing in peer-reviewed journals.

Compensation and Benefits:
The expected base salary range for this position is $180,000 - $240,000 annually. Actual compensation will be based on a variety of factors, including but not limited to a candidate’s level qualifications, experience, and skills.

SystImmune is a leading and well-funded biotech company with a bright future. We offer an opportunity for you to learn and grow while making significant contributions to the company’s success. SystImmune offers a comprehensive benefits package including: 100% paid employee premiums for medical/dental/vision, also STD, LTD, a 401(k) plan with a 50% company match of up to 3% and a vesting schedule of only 5 years, 15 PTO days per year, sick leave, plus 11 paid holidays and MORE.

We offer an opportunity for you to learn and grow while making significant contributions to the company’s success.

SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply.

About the Company

Systimmune

Develops bispecific antibodies and ADCs

Systimmune is a biopharmaceutical company that develops antibody-based cancer therapies, including bispecific and trispecific antibodies and antibody-drug conjugates (ADCs). These products are designed to act on the solid tumor micro-environment to directly attack tumors and/or to activate the immune system to fight cancer. The company uses multiple immuno-oncology platforms and experienced scientists to create biologics that intervene in the tumor environment in systematic ways. Compared with competitors, Systimmune emphasizes integrating several antibody-based modalities (bispecifics, trispecifics, and ADCs) and a deep focus on the solid tumor micro-environment, aiming to translate biological insight into targeted, immune-engaging therapies. The goal is to produce biologics that effectively modulate the tumor environment and mobilize the body's own immune response to destroy cancer cells.

Company size: 11-50
Company stage: Not listed
Total funding: Not listed
Headquarters: Redmond, WA
Founded: 2014

Recently Posted Jobs

Explore more opportunities at Systimmune

See more jobs